Abstract

Gout is a relatively common cause of legendary, severe pain as well as tophi, joint deformities, and nephropathy. Unlike most noninfectious diseases, frequently a pharmacologic “cure” for gout is attained. Shortcomings in the management of gout — due to poor patient education and compliance, substandard medical management, and drug toxicity — can perpetuate its adverse effects. The burden of gout is substantial, and recent epidemiologic studies suggest that it is increasing. This increase is probably due to risk factors related to lifestyle.1,2 Acute and chronic arthritis, tophi, and renal disease are manifestations of gout that reflect the magnitude and . . .

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.